RecruitingNCT05779813
Genetic Frontotemporal Dementia Initiative for Neurodevelopment
Sponsor
Western University
Enrollment
200 participants
Start Date
Mar 31, 2023
Study Type
OBSERVATIONAL
Conditions
Summary
This is an international multi-centre cohort study of first and second degree family members of individuals who carry Frontotemporal Dementia (FTD) mutations in MAPT, GRN or C9ORF72 repeat expansions for youths between the ages 9-17.
Eligibility
Min Age: 7 YearsMax Age: 17 Years
Plain Language Summary
Simplified for easier understanding
This clinical trial is studying a new treatment for people with family members and frontotemporal dementia. The study is currently recruiting participants at 1 location. People eligible for this study include aged 7 Years to 17 Years.
This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.
Interested in this trial?
Get notified about updates and connect with the research team.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT05779813
Related Trials
Investigating Complex Neurodegenerative Disorders Related to Amyotrophic Lateral Sclerosis and Frontotemporal Dementia
NCT032251441 location
Feasibility of the 5-Step Method in the U.S.
NCT065654291 location
Motivational Interviewing to Enhance Advance Care Planning for Older Adults and Caregivers After Emergency Visits
NCT060902401 location
GENetic Fronto Temporal Dementia Initiative in Lille
NCT046396221 location
Tanycytes in Alzheimer's Disease and Frontotemporal Dementia
NCT052888421 location